Aurobindo Pharma to Consider Share Buyback on April 6, 2026
Aurobindo Pharma Limited announced that a meeting of its Board of Directors will be held on Monday, April 6, 2026, to consider a proposal for the buyback of its fully paid-up equity shares. The meeting will also address related matters in accordance with the Companies Act, 2013, and applicable regulations.Trading window for the company's securities was closed for designated persons, connected persons, and their immediate relatives, effective April 1, 2026. This closure will remain in effect until 48 hours after the declaration of the company’s audited financial results for the financial year ending March 31, 2026, and includes the aforementioned buyback proposal.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.